Abstract
An O-aminated naphthol AS-E was designed as a prodrug to achieve reductive activation and improved aqueous solubility. During the synthesis of this designed compound, a novel transformation from aryl triflates and ethyl acetohydroximate to oxazoles was discovered. Although the initially designed O-amino naphthol AS-E was not made successfully, the eventually synthesized O-tert-butylamino derivative was found to be biologically inactive, suggesting that reductive N-O cleavage in this compound was not facile due to unfavorable steric and electronic effects.
Keywords: CREB, ethyl acetohydroximate, naphthol AS-E, oxazole, O-amination, prodrug, reductive activation.
Letters in Organic Chemistry
Title:Synthesis and Evaluation of an O-Aminated Naphthol AS-E as a Prodrug of CREB-mediated Gene Transcription Inhibition
Volume: 10 Issue: 5
Author(s): Fuchun Xie, Bingbing X. Li and Xiangshu Xiao
Affiliation:
Keywords: CREB, ethyl acetohydroximate, naphthol AS-E, oxazole, O-amination, prodrug, reductive activation.
Abstract: An O-aminated naphthol AS-E was designed as a prodrug to achieve reductive activation and improved aqueous solubility. During the synthesis of this designed compound, a novel transformation from aryl triflates and ethyl acetohydroximate to oxazoles was discovered. Although the initially designed O-amino naphthol AS-E was not made successfully, the eventually synthesized O-tert-butylamino derivative was found to be biologically inactive, suggesting that reductive N-O cleavage in this compound was not facile due to unfavorable steric and electronic effects.
Export Options
About this article
Cite this article as:
Xie Fuchun, Li Bingbing X. and Xiao Xiangshu, Synthesis and Evaluation of an O-Aminated Naphthol AS-E as a Prodrug of CREB-mediated Gene Transcription Inhibition, Letters in Organic Chemistry 2013; 10 (5) . https://dx.doi.org/10.2174/1570178611310050014
DOI https://dx.doi.org/10.2174/1570178611310050014 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thiosemicarbazone Derivative Induces in vitro Apoptosis in Metastatic PC-3 Cells via Activation of Mitochondrial Pathway
Anti-Cancer Agents in Medicinal Chemistry Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Current Neuropharmacology Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Current Drug Metabolism Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Current Drug Safety Graphical Abstracts:
Anti-Cancer Agents in Medicinal Chemistry Dietary Interventions for Atopic Disorders
Current Pharmaceutical Design COXIBs, CINODs and H2S-Releasing NSAIDs: Current Perspectives in the Development of Safer Non Steroidal Anti-Inflammatory Drugs
Current Medicinal Chemistry Adenosine Analogues as Opposite Modulators of the Cisplatin Resistance of Ovarian Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers Targeted Histone Deacetylase Inhibition for Cancer Therapy
Current Cancer Drug Targets Editorial (Thematic Issue:Nanotechnology for Drug Delivery: Part III)
Current Pharmaceutical Design The Peripheral Benzodiazepine Receptor: A Promising Therapeutic Drug Target
Current Medicinal Chemistry Substrate Phage as a Tool to Identify Novel Substrate Sequences of Proteases
Combinatorial Chemistry & High Throughput Screening High Throughput Optimization of Stem Cell Microenvironments
Combinatorial Chemistry & High Throughput Screening Kinase CK2 Inhibition: An Update
Current Medicinal Chemistry Histopathology of Ductal Carcinoma in Situ (DCIS) of the Breast
Current Cancer Therapy Reviews A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015
Current Medicinal Chemistry Acknowledgements to the Reviewers
Current Cancer Drug Targets The HOX Gene Network as a Potential Target for Cancer Therapy
Current Cancer Therapy Reviews